Deva Holding As Cerkezkoy Subesi recalls

Deva Holding As Cerkezkoy Subesi appears in 6 official U.S. recall notices indexed by RecallRadar, most recently on 2019-07-31.

Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.

• Temozolomide Capsules, 180 mg, packaged in a) 5-count bottle (NDC 67877-541-07), b) 14-count bottle (NDC 67877-541-14), Rx only, Manufactur…
  FDA Drug · Class II · 2019-07-31 · Deva Holding As Cerkezkoy Subesi
• Temozolomide Capsules, 20 mg, packaged in a) 5-count bottle (NDC 67877-538-07), b) 14-count bottle (NDC 67877-538-14), Rx only, Manufacture…
  FDA Drug · Class II · 2019-07-31 · Deva Holding As Cerkezkoy Subesi
• Temozolomide Capsules, 100 mg, packaged in a) 5-count bottle (NDC 67877-539-07), b) 14-count bottle (NDC 67877-539-14), Rx only, Manufactur…
  FDA Drug · Class II · 2019-07-31 · Deva Holding As Cerkezkoy Subesi
• Temozolomide Capsules, 5 mg, packaged in a) 5-count bottle (NDC 67877-537-07), b) 14-count bottle (NDC 67877-537-14), Rx only, Manufactured…
  FDA Drug · Class II · 2019-07-31 · Deva Holding As Cerkezkoy Subesi
• Temozolomide Capsules, 140 mg, packaged in a) 5-count bottle (NDC 67877-540-07), b) 14-count bottle (NDC 67877-540-14), Rx only, Manufactur…
  FDA Drug · Class II · 2019-07-31 · Deva Holding As Cerkezkoy Subesi
• Temozolomide Capsules, 250 mg, 5-count bottle, Rx only, Manufactured by: Deva Holding A.S., 1 Merkez Mahallesi, Istanbul, Turkey 34303, Dis…
  FDA Drug · Class II · 2019-07-31 · Deva Holding As Cerkezkoy Subesi